MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

The present invention features a compound of formula I:or a pharmaceutically acceptable salt thereof, where R1, R2, R3, W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FRIEMAN, BRYAN, A, NICHOLLS, GEORGIA, MCGAUGHEY, LIN, CHUNIEH, CONROY, ERICA, PIERRE, FABRICE, JEAN, DENIS, KHATUYA, HARIPADA, MILLER, MARK, THOMAS, ZHOU, JINGLAN, JOSHI, PRAMOD, VIRUPAX, MCCARTNEY, JASON, ARUMUGAM, VIJAYALAKSMI, SILINA, ALINA, COON, TIMOTHY, RICHARD, CLEVELAND, THOMAS, CLEMENS, JEREMY, J, KRENITSKY, PAUL, JOHN, ANDERSON, COREY, GROSS, RAYMOND, STANLEY, BEAR, BRIAN, RICHARD, TERMIN, ANDREAS, P, MELILLO, VITO, GROOTENHUIS, PETER, DIEDERIK, JAN, HADIDA-RUAH, SARA, SABINA, UY, JOHNNY, BINCH, HAYLEY, MARIE, MARELIUS, GULIN, ERDOGAN
Format: Patent
Sprache:eng ; srp
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention features a compound of formula I:or a pharmaceutically acceptable salt thereof, where R1, R2, R3, W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions, method of treating, and kits thereof.